• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011

tetano

Editor, Senior Moderator
J Gen Virol. 2012 Sep 5. [Epub ahead of print]
Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011.
El-Shesheny RA, Kayali G, Kandeil A, Cai Z, Barakat AB, Ghanim HE, Ali MA.
Source

National Research Center, Giza, Egypt;
Abstract

Influenza epidemics are major health concern worldwide. Highly pathogenic avian influenza (HPAI) H5N1 viruses in Egypt have been subject to rapid genetic and antigenic changes since the first outbreak in February 2006 and have been endemic in poultry in Egypt since 2008. In this study, 32 H5N1 viruses isolated from avian hosts were antigenically analyzed by using a panel of 8 monoclonal antibodies raised against the A/Vietnam/1203/04 (H5N1) and A/bar-headed goose/Qinghai-lake/1A/05 (H5N1) influenza viruses. Eight antigenically different HPAI H5N1 virus isolates were selected and converted to rescue viruses and immunized rats to produce polyclonal antibodies. Cross-reactivity between the obtained polyclonal antibodies and the isolated viruses was assayed. Antigenic cartography of the isolated viruses showed 6 antigenically different groups. Viruses isolated in 2010 and 2011 were in two separate groups, suggesting the necessity of a bivalent vaccine. An antigenic map produced from the antigenic data showed that one extended cluster included all virus isolates. Accordingly, continuous surveillance and antigenic characterization will help us to determine which virus isolate(s) should be used in vaccine preparation.

PMID:
22956735
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22956735
 
Back
Top Bottom